Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion type Assertion NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_head.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion description "[Carriers of 719Arg receive significantly greater benefit from intensive statin therapy than do noncarriers, a superior benefit that appears to be due to a mechanism distinct from lipid or CRP lowering.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion evidence source_evidence_literature NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion SIO_000772 18222355 NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion wasDerivedFrom gad-20150221 NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.
- NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_assertion wasGeneratedBy ECO_0000203 NP118094.RAOyBu8xmnok_A4norkXs_mIyzBQ-F_hFn-XcWQHmIX14130_provenance.